BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 37821244)

  • 1. Accuracy of 3-D Surface Rendering of 2-D Ultrasound Images of the Uterus Using a Novel Software in Mapping Uterine Fibroids.
    Guruvare S; Hebbar S; Bai L; Jaiprakash P; Reddy D; Hc D
    Ultrasound Med Biol; 2024 Jan; 50(1):128-133. PubMed ID: 37821244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A single baseline ultrasound assessment of fibroid presence and size is strongly predictive of future uterine procedure: 8-year follow-up of randomly sampled premenopausal women aged 35-49 years.
    Baird DD; Saldana TM; Shore DL; Hill MC; Schectman JM
    Hum Reprod; 2015 Dec; 30(12):2936-44. PubMed ID: 26409013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A tissue preparation to characterize uterine fibroid tissue properties for thermal therapies.
    Dillon C; Rezvani M; McLean H; Adelman M; Dassel M; Jarboe E; Janát-Amsbury M; Payne A
    Med Phys; 2019 Aug; 46(8):3344-3355. PubMed ID: 31152601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The estimated volume of the fibroid uterus: a comparison of ultrasound and bimanual examination versus volume at MRI or hysterectomy.
    Stoelinga B; Huirne J; Heymans MW; Reekers JA; Ankum WM; Hehenkamp WJ
    Eur J Obstet Gynecol Reprod Biol; 2015 Jan; 184():89-96. PubMed ID: 25481364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The management of uterine leiomyomas.
    Lefebvre G; Vilos G; Allaire C; Jeffrey J; Arneja J; Birch C; Fortier M; Wagner MS;
    J Obstet Gynaecol Can; 2003 May; 25(5):396-418; quiz 419-22. PubMed ID: 12738981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The management of uterine leiomyomas.
    Vilos GA; Allaire C; Laberge PY; Leyland N;
    J Obstet Gynaecol Can; 2015 Feb; 37(2):157-178. PubMed ID: 25767949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of ultrasound-guided high intensity focused ultrasound for the treatment of uterine fibroids in patients with an anteverted uterus and a retroverted uterus.
    Zhang W; He M; Huang G; He J
    Int J Hyperthermia; 2016 Sep; 32(6):623-9. PubMed ID: 27328887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and clinical evaluation of a 3-step modified manipulation protocol for MRI-guided high-intensity focused ultrasound of uterine fibroids.
    Verpalen IM; van 't Veer-Ten Kate M; de Boer E; van den Hoed RD; Schutte JM; Dijkstra JR; Franx A; Bartels LW; Moonen CTW; Boomsma MF
    Eur Radiol; 2020 Jul; 30(7):3869-3878. PubMed ID: 32166489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic management of uterine fibroid tumors: updated French guidelines.
    Marret H; Fritel X; Ouldamer L; Bendifallah S; Brun JL; De Jesus I; Derrien J; Giraudet G; Kahn V; Koskas M; Legendre G; Lucot JP; Niro J; Panel P; Pelage JP; Fernandez H;
    Eur J Obstet Gynecol Reprod Biol; 2012 Dec; 165(2):156-64. PubMed ID: 22939241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Magnetic resonance-high intensity focused ultrasound (MR-HIFU) therapy of symptomatic uterine fibroids with unrestrictive treatment protocols: A systematic review and meta-analysis.
    Verpalen IM; Anneveldt KJ; Nijholt IM; Schutte JM; Dijkstra JR; Franx A; Bartels LW; Moonen CTW; Edens MA; Boomsma MF
    Eur J Radiol; 2019 Nov; 120():108700. PubMed ID: 31634683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uterine artery ligation for management of uterine fibroids.
    Akinola OI; Fabamwo AO; Ottun AT; Akinniyi OA
    Int J Gynaecol Obstet; 2005 Nov; 91(2):137-40. PubMed ID: 16168993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term health-related quality of life and symptom severity following hysterectomy, myomectomy, or uterine artery embolization for the treatment of symptomatic uterine fibroids.
    Anchan RM; Spies JB; Zhang S; Wojdyla D; Bortoletto P; Terry K; Disler E; Milne A; Gargiulo A; Petrozza J; Brook O; Srouji S; Morton CC; Greenberg J; Wegienka G; Stewart EA; Nicholson WK; Thomas L; Venable S; Laughlin-Tommaso S; Diamond MP; Maxwell GL; Marsh EE; Myers ER; Vines AI; Wise LA; Wallace K; Jacoby VL
    Am J Obstet Gynecol; 2023 Sep; 229(3):275.e1-275.e17. PubMed ID: 37244458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uterine structural abnormality and intrauterine device malposition: analysis of ultrasonographic and demographic variables of 517 patients.
    Gerkowicz SA; Fiorentino DG; Kovacs AP; Arheart KL; Verma U
    Am J Obstet Gynecol; 2019 Feb; 220(2):183.e1-183.e8. PubMed ID: 30419198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreasing margins to the uterine serosa as a method for increasing the volume of fibroids ablated with magnetic resonance-guided focused ultrasound surgery.
    Morita Y; Takeuchi S; Hikida H; Ohashi H; Ito N
    Eur J Obstet Gynecol Reprod Biol; 2009 Sep; 146(1):92-5. PubMed ID: 19481328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of contrast-enhanced ultrasonography in MR-guided focused ultrasound ablation on uterus fibroids: lesion selection and assessment of ablative effects.
    Luo W; Zhang PD; Yang X; Zheng JM; Liu Y; Tang X; Liu HJ; Ding L; Pang LN; Zhou XD; Liu LW; Zheng MW
    Eur Radiol; 2022 Mar; 32(3):2110-2119. PubMed ID: 34751794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A multi-centre retrospective cohort study comparing the efficacy, safety and cost-effectiveness of hysterectomy and uterine artery embolisation for the treatment of symptomatic uterine fibroids. The HOPEFUL study.
    Hirst A; Dutton S; Wu O; Briggs A; Edwards C; Waldenmaier L; Maresh M; Nicholson A; McPherson K
    Health Technol Assess; 2008 Mar; 12(5):1-248, iii. PubMed ID: 18331704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pre-operative GnRH analogue therapy before hysterectomy or myomectomy for uterine fibroids.
    Lethaby A; Vollenhoven B; Sowter M
    Cochrane Database Syst Rev; 2001; (2):CD000547. PubMed ID: 11405968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic response assessment of high intensity focused ultrasound therapy for uterine fibroid: utility of contrast-enhanced ultrasonography.
    Zhou XD; Ren XL; Zhang J; He GB; Zheng MJ; Tian X; Li L; Zhu T; Zhang M; Wang L; Luo W
    Eur J Radiol; 2007 May; 62(2):289-94. PubMed ID: 17258417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. First experience of real-time elastography with transvaginal approach in assessing response to MRgFUS treatment of uterine fibroids.
    Marigliano C; Panzironi G; Molisso L; Pizzuto A; Ciolina F; Napoli A; Ricci P
    Radiol Med; 2016 Dec; 121(12):926-934. PubMed ID: 27586131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feasibility of quantitative MR-perfusion imaging to monitor treatment response after uterine artery embolization (UAE) in symptomatic uterus fibroids.
    Sadick M; Richers J; Tuschy B; Schad LR; Schoenberg SO; Zöllner FG
    Magn Reson Imaging; 2019 Jun; 59():31-38. PubMed ID: 30807812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.